Ultrasound-guided totally implantable venous access ports placement via right brachiocephalic vein in pediatric population: A clinical debut
- PMID: 35880972
- DOI: 10.1002/pbc.29911
Ultrasound-guided totally implantable venous access ports placement via right brachiocephalic vein in pediatric population: A clinical debut
Abstract
Background and objectives: To investigate the feasibility and safety of ultrasound-guided totally implantable venous access ports (TIVAPs) via the right brachiocephalic vein (BCV) in pediatric patients.
Methods: A single-institute retrospective review was performed on 35 pediatric patients with predominantly hematological malignancies (88.6%) who underwent TIVAP implantation via ultrasound-guided right BCV approach from July 2018 to June 2021. The catheter tip was adjusted to be positioned at the cavoatrial junction under pulsed fluoroscopic guidance. Technical success rate, procedural information, and TIVAP-related complications were evaluated.
Results: All the pediatric TIVAP devices were successfully implanted via right BCV access. Venous access was successful by first attempt in 32 children (91%), two cases (5.7%) required a second attempt, and one patient (2.9%) required a third attempt. The mean procedural time was 44.6 ± 6.4 minutes (range: 34-62 minutes). No intraoperative complications occurred. The average TIVAP indwelling time was 564 ± 208 days (range: 193-1014 days), with a cumulative 19,723 catheter-days. Overall, three patients (8.6%) experienced four postoperative complications (two cases of local hematoma and two catheter dysfunctions) at a rate of 0.2 per 1000 catheter-days. No other complications such as wound dehiscence, delayed incision healing, catheter-related thrombosis (CRT), catheter malposition/fracture, surgical site infection, catheter-related bloodstream infection (CRBSI), pinch-off syndrome, and drug extravasation were observed during follow-up.
Conclusions: Ultrasound-guided right BCV access for TIVAP placement in pediatric patients appears to be technically feasible, safe, and effective. Further large-sample, prospective studies are warranted.
Keywords: brachiocephalic vein; feasibility; pediatric patient; safety; totally implantable venous access port; ultrasound guided.
© 2022 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Similar articles
-
Efficacy and safety of ultrasound-guided totally implantable venous access ports via the right innominate vein in adult patients with cancer: Single-centre experience and protocol.Eur J Surg Oncol. 2019 Feb;45(2):275-278. doi: 10.1016/j.ejso.2018.07.048. Epub 2018 Jul 26. Eur J Surg Oncol. 2019. PMID: 30087070
-
Clinical application of ultrasound-guided totally implantable venous access ports implantation via the posterior approach of the internal jugular vein.J Chin Med Assoc. 2024 Jan 1;87(1):126-130. doi: 10.1097/JCMA.0000000000001030. Epub 2024 Jan 4. J Chin Med Assoc. 2024. PMID: 38016115
-
Perioperative and Postoperative Complications of Supraclavicular, Ultrasound-Guided, Totally Implantable Venous Access Port via the Brachiocephalic Vein in Adult Patients: A Retrospective Multicentre Study.Ther Clin Risk Manag. 2021 Feb 4;17:137-144. doi: 10.2147/TCRM.S292230. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 33568912 Free PMC article.
-
A novel incision technique of a totally implanted venous access port in the upper arm for patients with breast cancer.World J Surg Oncol. 2023 May 27;21(1):162. doi: 10.1186/s12957-023-03043-4. World J Surg Oncol. 2023. PMID: 37237419 Free PMC article. Review.
-
Systemic thrombolysis and anticoagulation therapy for catheter-related right atrial thrombosis caused by TIVAP: A case report and review of the literature.J Vasc Access. 2022 Mar;23(2):313-317. doi: 10.1177/1129729821989159. Epub 2021 Jan 28. J Vasc Access. 2022. PMID: 33506722 Review.
Cited by
-
Clinical applications and research progress of totally implantable venous access ports: a literature review.Front Oncol. 2025 Jan 16;14:1519728. doi: 10.3389/fonc.2024.1519728. eCollection 2024. Front Oncol. 2025. PMID: 39886665 Free PMC article. Review.
References
REFERENCES
-
- Bhakta N, Force LM, Allemani C, et al. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019;20:e42-e53.
-
- Beck O, Muensterer O, Hofmann S, et al. Central venous access devices (CVAD) in pediatric oncology patients - a single-center retrospective study over more than 9 years. Front Pediatr. 2019;7:260.
-
- Ullman AJ, Gibson V, Takashima MD, et al. Pediatric central venous access devices: practice, performance, and costs. Pediatr Res. 2022;8. https://doi.org/10.1038/s41390-022-01977-1
-
- Gonella S, Antonuzzo A, Bossi P. Peripherally or centrally inserted central catheters: what is the best vascular access device for cancer patients? Support Care Cancer. 2021;29:2803-2806.
-
- Wang K, Zhou Y, Huang N, Lu Z, Zhang X. Peripherally inserted central catheter versus totally implanted venous port for delivering medium- to long-term chemotherapy: a cost-effectiveness analysis based on propensity score matching. J Vasc Access. 2022;23:365-374.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials